Strain Information | |
---|---|
Image | ![]() |
BRC No. | RBRC00857 |
Type | Targeted Mutation![]() |
Species | Mus musculus |
Strain name | B6.Cg-Treh<tm1Tkam>/Rbrc |
Former Common name | trehalase Knockout mice |
H-2 Haplotype | |
ES Cell line | TT2 [(C57BL/6NCrlj x CBA/JNCrlj)F1] |
Background strain | C57BL/6JJcl |
Appearance | black [a/a B/B C/C] |
Strain development | Developed by Dr. Masashi Kurimoto, Biochemical Laboratories, Inc. in 2001-2002. A neomycin selection cassette replaced exons 5-10 of the Treh gene. |
Strain description | B6;B6CB-Treh<tm1Tkam>. Targeted disruption of the trehalase gene. The mice with this mutant allele lack the trehalase activity in small intestine and kidney. |
Colony maintenance | Sibling x Sibling (Homozygote x Homozygote)Homozygous mutant mice are viable and fertile. |
References | Nutr. Res., 23, 287-298 (2003). Trehalose itself plays a critical role on lipid metabolism: Trehalose increases jejunum cytoplasmic lipid droplets which negatively correlated with mesenteric adipocyte size in both HFD-fed trehalase KO and WT mice. Chikako Arai, Aki Suyama, Shigeyuki Arai, Norie Arai, Chiyo Yoshizane, Satomi Koya-Miyata, Akiko Mizote, Shin Endo, Toshio Ariyasu, Hitoshi Mitsuzumi, Shimpei Ushio Nutr. Metab. (Lond), 17:22 (2020). 32206077 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Treh MGI:1926230 | trehalase (brush-border membrane glycoprotein) | 9 | Treh<tm1Tkam> MGI:3586558 | targeted mutation 1, Takashi Kamiya | |||
neo | neomycin resistance gene (E. coli) | 9 | mouse phosphoglycerate kinase promoter (PGK promoter) |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | mouse phosphoglycerate kinase promoter (PGK promoter), E. coli neo, mouse trehalase genomic DNA |
Research application | |
Specific Term and Conditions | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Nutr. Res., 23, 287-298 (2003). In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form (Contact info: Shin Endo <shin.endo@hb.nagase.co.jp>, Hayashibara Co., Ltd.). The RECIPIENT is permitted to use the BIOLOGICAL RESOURCE only for the purpose of not-for-profit academic research. Any patent application relating to the results of the research conducted by using the BIOLOGICAL RESOURCE hereunder may not be filed without prior written consent of the DEPOSITOR. The RECIPIENT promises not to make any claim or other actions to restrict the using of the BIOLOGICAL RESOURCE by the DEPOSITOR, RIKEN BRC and any other parties receiving it from the DEPOSITOR or RIKEN BRC. The DEPOSITOR shall not be liable for RECIPIENT's performance and nonperformance in relation to the BIOLOGICAL RESOURCE between RECIPIENT and RIKEN BRC. |
Depositor | Masashi Kurimoto (Hayashibara Biochemical Laboratories, Inc.) |
Strain Status | ![]() ![]() |
Strain Availability | Recovered litters from cryopreserved embryos (2 to 4 months) Cryopreserved sperm (within 1 month) Cryopreserved embryos (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |